melocotón

Peach (Prunus persica (L.) Batsch): A Comprehensive Reference

1. Identity and Botanical Classification

Nomenclature and Taxonomy

The peach (Prunus persica L. Batsch), which belongs to the subfamily Prunoideae of the family Rosaceae, is one of the economically important fruits in the world. The full accepted scientific name is Prunus persica (L.) Batsch; a widely used synonym is Amygdalus persica L. The epithet persica reflects a historical geographic error: peaches were moved to Persia (Iran) along silk trading routes, and the epithet persica denotes Persia, which is where Europeans thought peaches originated. Nectarines, which differ only by the absence of the fuzz gene, are classified within the same species as Prunus persica var. nucipersica (or simply Prunus persica). Its subgenus, Amygdalus, is distinguished from other subgenera by the corrugated seed shell of the fruit.

Morphology and Fruit Types

Technically, peach fruit is a "drupe" having similar features as that of other Prunus members including plums, nectarines, almonds, and damson. The peach is described as a small deciduous tree. It grows up to 25 to 30 feet tall and is widely grown in the United States, Europe, and China for its juicy fruits. Peaches are classified as either clingstone or freestone, depending on whether the flesh adheres to the stone or not. There are early and late varieties, fruit with white, yellow or red flesh, and dwarf varieties which can be grown in containers.

Common Forms and Preparations

Peach is consumed and prepared in numerous forms across food, nutraceutical, and traditional medicine contexts. During the consumption of peach fruit, jams, jellies, juices, and other food products are common preparations, while the seed and kernel (stone) is typically disposed of as waste during industrial processing. In herbal and traditional medicine, the parts used include the fruit pulp and peel, the leaves (as infusions and decoctions), the flowers, the bark, and the dried or powdered seed kernel. Supplemental forms include liquid extracts, capsules, powders, and essential oils pressed from the flowers or kernel.

Global Production

In 2022, global peach and nectarine production reached a total of 43,171,565 tonnes. Among the leading producers, the top seven countries were: China (16,800,000 tonnes), Italy (1,151,490 tonnes), Türkiye (1,008,185 tonnes), Greece (894,510 tonnes), Spain (870,720 tonnes), the United States of America (666,490 tonnes), and Iran (577,295 tonnes).

2. Origins and Historical Background

Botanical Origins

Analyses suggest that peach originated about 2.47 million years ago in southwest China in glacial refugia generated by the uplift of the Tibetan plateau. Archaeological evidence firmly places its domestication in China: five populations of archaeological peach stones recovered from Zhejiang Province, China, document peach use and evolution beginning approximately 8,000 years before present (BP). The majority of the earliest archaeological sites are from the Yangzi River valley, indicating that this is where early selection for favorable peach varieties likely took place. The oldest archaeological peach stones are from the Kuahuqiao (8,000–7,000 BP) and Tianluoshan (7,000–6,500 BP) sites; the first peach stones in China most similar to modern cultivated forms are from the Liangzhu culture (ca. 5,300 to 4,300 BP), where the stones are significantly larger and more compressed than earlier specimens.

Dispersal via the Silk Road

Domesticated peach in China was dispersed westward to Europe via the ancient Silk Road through Persia (present-day Iran) in the final centuries B.C., and from Europe to the Americas during the 16th century. The peach eventually migrated west into Persia and Greece via the Silk Road, arriving in Greece around 300 BCE. By the Middle Ages, the peach was being grown in Italy, France, and Spain. Peaches came to the New World with explorers of the 16th–17th centuries, with the Portuguese introducing it to South America and Spaniards to the northern Florida coast of North America.

3. Traditional and Historical Uses

Traditional Chinese Medicine (TCM)

Peach trees were among the first fruit crops to be domesticated in China for both culinary and medicinal purposes, and peaches have held great cultural significance in many Asian countries throughout the years. In TCM, it is primarily the seed kernel (known as Taoren or Persicae Semen) rather than the fruit that is used medicinally. Persicae Semen (Taoren), the seed of mature peaches, is consumed as both food and medicine and is native to the temperate regions of China. The primary components of Persicae Semen include volatile oil, protein, amino acids, amygdalin, and prunasin, all of which have pharmacological properties such as anti-inflammatory, antioxidant, and immune regulatory effects, and are clinically used in the treatment of gynecological, cardiovascular, cerebrovascular, orthopedic, and digestive system diseases. Traditional Chinese medicine has used the pit of peaches for treating blood stasis, constipation, and inflammation.

Other Traditional Systems

Peach has a long history of use as a medicine, including in Unani Tibb, Ayurveda, Physiomedicalism, and Appalachian/Southern folk herbalism. In the Western world, peaches have been used for gastrointestinal problems such as vomiting, worms, and upset stomach, as well as kidney stones. In European herbal medicine, the leaves, flowers, and seeds were applied for digestive issues, skin conditions, and as mild sedatives. In Appalachian folk herbalism, the leaf was traditionally prepared as an infusion or elixir, with a strong peach leaf decoction sometimes taken as a laxative to clear out intestinal worms.

Cultural and Ritual Uses

All parts of the peach tree — wood, blossoms, fruit, and pit — have been traditionally associated with springtime, fertility, and especially longevity in Asian cultures. Peach flowers were used in early Chinese healing and ritual practices, where they were believed to repel demons and insects.

4. Key Constituents and Active Compounds

Polyphenolic Compounds

The peach has been part of the human diet for hundreds of years and is very rich in phytochemicals like phenolic compounds, carotenoids, vitamins, volatiles and organic acids. Research has identified a complex polyphenolic profile. Neochlorogenic acid (NCHA), chlorogenic acid (CHA), procyanidin B1, catechin (CAT), cyanidin-3-O-glucoside, quercetin-3-O-galactoside, quercetin-3-O-glucoside, quercetin-3-O-rutinoside, and kaempferol-3-O-rutinoside have been identified and quantified in peach, with chlorogenic acid and catechin being the predominant components in both the peel and pulp. A study of peach pulp extract by HPLC-ESI-MS/MS further identified gallic acid, protocatechuic acid, protocatechualdehyde, chlorogenic acid, p-coumaric acid, and ferulic acid as main constituents.

Total phenolic concentration is approximately three-fold higher in the exocarp (skin) than the mesocarp (flesh) across accessions, a finding consistently reported across multiple independent studies. The red-flesh selection demonstrated the highest levels of phenolic compounds and ascorbic acid. The study showed substantial differences in the chemical composition of peach fruit depending on the cultivar; varieties with light flesh were characterized by a high content of phenolic acids and flavonols, while yellow varieties with high content of carotenoids showed high inhibitory activity toward porcine pancreatic lipase.

Peaches (Prunus persica) contain anthocyanins, beta-carotene, catechin, chlorogenic acid, epicatechin, lignans, oleanolic acid, quercetin, and vitamin C.

Carotenoids

The most abundant carotenoids in yellow-fleshed peaches include α- and β-carotene (both vitamin A precursors), cryptoxanthin, lutein, and zeaxanthin, while only traces are found in white-fleshed fruits. In peaches, violaxanthin is the predominant xanthophyll both in the skin and in the flesh and can be found in amounts up to three times higher than other carotenoids. Values are highly influenced by post-harvest treatments including refrigeration, and lower temperatures slow down carotenoid biosynthesis.

Vitamins and Minerals

Vitamin C (ascorbic acid and dehydroascorbic acid) is an important bioactive compound that confers health-promoting properties to fruits and is found in similar amounts in peaches and nectarines. Peaches are rich in bioactive compounds including vitamins (especially vitamin C and A), polyphenols, and dietary fiber, which have been linked to antioxidant, anti-inflammatory, anti-obesity, and cardioprotective properties.

Kernel (Seed) Constituents

The seeds and kernels of peach fruit are considered remarkably rich sources of sodium, potassium, zinc, copper, iron, fatty acids (linolenic, oleic, palmitic, and linoleic acids), fiber, and carbohydrate (sucrose, glucose, and fructose) content. Preliminary results of various studies demonstrated that seed and kernels of peach fruit contain high amounts of protein and bioactive peptides. A critical kernel constituent is amygdalin: amygdalin is a natural cyanogenic glycoside occurring in the seeds of some edible plants, such as bitter almonds and peaches. Amygdalin is composed of two molecules of glucose, benzaldehyde, and hydrogen cyanide. Peach kernels contain approximately 6.8 g/kg amygdalin.

The biological properties of peach kernel are stimulated by the presence of hydroxycinnamic acids, polymeric procyanidins, cyanogenic glycosides, carotenoids, and other metabolites.

Mechanisms of Action

Phenolics, carotenoids, and vitamins are known for their antioxidant properties. They exert a number of beneficial effects on cells through free radical scavenging and by participating in cells' signaling pathways. The phenolic compounds in peach — such as quercetin, catechins, and cyanidin derivatives — have been found to play important roles due to their antioxidant, antimicrobial, and anti-inflammatory properties.

Chemoprotective actions of polyphenolic-rich extracts of Prunus persica L. Batsch have been linked with a range of protective pathways such as free radical scavenging action, carcinogen modulation, and regulation of xenobiotic metabolizing enzymes.

For cardiovascular mechanisms, a laboratory study found that the vasorelaxant effect of a P. persica branch extract was endothelium-dependent, and it was related to the NO-sGC-cGMP, vascular prostacyclin, and muscarinic receptor transduction pathway. K⁺ channels, such as the BKCa, KV, and KATP channels, were partially associated with extract-induced vasorelaxation. In the context of the broader genus, the peach fruit has also shown cardiovascular protective effects by inhibiting angiotensin II-induced signal transduction in vascular smooth muscle cells.

For metabolic enzyme inhibition, studies have examined the health properties of Prunus persica fruit related to their polyphenol and carotenoid profiles, antioxidant capacity, and in vitro potential to inhibit enzymes relevant to type 2 diabetes (α-amylase, α-glucosidase) and obesity (pancreatic lipase) management.

Regarding amygdalin's mechanism at the cellular level: beta-glucosidase stored in compartments of plant cells is also present in the human small intestine and degrades amygdalin into prunasin, mandelonitrile, glucose, benzaldehyde, and hydrogen cyanide. Cyanide acts through the inhibition of cytochrome-c oxidase in the respiratory electron transport chain of the mitochondria, impairing both oxidative metabolism and the associated process of oxidative phosphorylation.

5. Scientific Evidence by Area of Use

5.1 Antioxidant Activity

The antioxidant properties of peach extracts have been evaluated across numerous in vitro studies. Total phenol, flavonoid, and carotenoid content, as well as antioxidant properties, were evaluated using different in vitro assays including DPPH, ABTS, FRAP, Fe-chelating, and the β-carotene bleaching test. Pulp extract was characterized by the highest total phytonutrient content and exhibited the highest antioxidant activity across in vitro assays (IC₅₀ values of 2.2 µg/mL after 60 minutes using the β-carotene bleaching test and 2.9 µg/mL using the Fe-chelating assay). In general, peel extracts showed higher antioxidant activities than the pulp counterparts, consistent with the observed higher phenolic content.

An ex vivo study comparing fresh and preserved peach products found that fresh peach pulps, peels, preserved peach pulps, and preserve syrup were prepared at equal concentrations. Rat liver, kidney, and brain cortex tissue slices were pre-incubated with peach samples and subjected to oxidative stress with FeSO₄ and hydrogen peroxide. Fresh peach pulps and peel conferred higher protection against cytotoxicity and oxidative stress than preserve peach pulps in most tissues. Release of tumor necrosis factor-α and interleukin-1β was also significantly decreased by fresh peach pulps and peel. Total phenolic determination showed that the content of secondary metabolites in fresh peach pulps and peel is significantly higher than in preserved products.

Evidence characterization: Evidence is predominantly in vitro and ex vivo. No large-scale, controlled human clinical trials specifically measuring peach consumption's antioxidant effect as a primary endpoint have been identified in the literature reviewed.

5.2 Metabolic Health: Type 2 Diabetes and Obesity

Several in vitro and animal-based studies have investigated peach's potential against metabolic disease. Varieties with light flesh, characterized by a high content of phenolic acids and flavonols, exhibited high activity against α-amylase in vitro, while the yellow varieties with high carotenoid content showed high inhibitory activity toward porcine pancreatic lipase. The study showed that peach fruit is an interesting raw material with a varied chemical composition, especially with high inhibitory potential against digestive enzymes linked to obesity and type 2 diabetes, strongly determined by the cultivar.

A rodent-based study examined the effects of polyphenol-rich peach and plum juice in Zucker rats, a model of genetic obesity. The goal of this study was to investigate the cluster of mechanisms being modulated by consumption of polyphenol-rich peach and plum juice that are related to obesity-induced metabolic disorders and cardiovascular disease risk. Results were consistent with previous reports showing that polyphenols catechins and anthocyanins, found in plums and peaches, modulate physiological disorders in obesity and reduce liver and body weights.

In a rat model, a study designed to demonstrate the potential protective effect of P. persica leaf extract against metabolic syndrome and oxidative stress in rats fed a high-fructose diet revealed the rich composition of bioactive substances such as polyphenols, flavonoids, flavonols, and condensed tannins in the organic acidic extracts from this plant.

At the broader level of dietary polyphenols and human metabolic syndrome, several epidemiological studies have observed a negative association between polyphenol intake and metabolic syndrome rates; nevertheless, there are relatively small numbers of interventional studies evidencing this association.

Evidence characterization: Evidence for peach-specific effects on human metabolic parameters is preliminary and indirect. Most data derive from animal models and in vitro enzyme-inhibition studies. Human clinical trials using peach or peach extract as an isolated intervention in metabolic syndrome patients have not been established in the reviewed literature. Peach findings cannot be separated from the broader polyphenol literature without dedicated human trials.

5.3 Cardiovascular Health

Epidemiological studies have shown that the consumption of fruit and vegetables has health benefits against chronic diseases, such as cardiovascular disease, cancer, and diabetes. For peach specifically, the available mechanistic evidence is preclinical. Plants from the genus Prunus such as P. yedoensis, P. cerasus, and P. serotina have shown vasorelaxant and vasodilatory effects, and investigations of P. persica branch extract have extended this finding to the peach species in isolated tissue preparations. The P. cerasus fruit (Montmorency tart cherry) significantly lowered systolic blood pressure in men with early hypertension in a published study, and P. serotina induced vasodilation via the NO/cGMP and H₂S/KATP channel pathways.

Evidence characterization: Cardiovascular evidence for peach specifically remains at the preclinical stage (isolated tissue and animal models). No peach-specific human intervention trials for cardiovascular outcomes were identified in the reviewed literature.

5.4 Anti-Cancer Properties

Research groups at Texas A&M University have conducted a series of in vitro and in vivo animal studies on peach polyphenolics and breast cancer cell lines. The objective was to evaluate the cancer suppression activity of extracts from a commercial variety of yellow-fleshed peach 'Rich Lady' (RL). The peach RL extract effectively inhibited the proliferation of the estrogen-independent MDA-MB-435 breast cancer cell line.

Polyphenolic extracts and fractions of selected peach and plum genotypes were evaluated for cell viability and antiproliferation activity in vitro against an estrogen-independent MDA-MB-435 and estrogen-dependent MCF-7 breast cancer cell line and one non-cancerous breast line MCF-10A. All extracts showed a phenolic dose-dependent cytotoxic effect against MDA-MB-435, weak activity against MCF-7, and small or no activity against MCF-10A. Fractionation of peach BY00P6653 extracts gave 4 fractions, with fraction F-I (caffeic acid derivatives) showing the strongest activity against MDA-MB-435, followed by fraction F-II (anthocyanins).

An in vivo xenograft study further confirmed these signals: the tumor growth inhibition and anti-metastatic effects of peach polyphenolics were investigated in vivo using a xenograft model and MDA-MB-435 breast cancer cells. Tumor growth and lung metastasis were inhibited in vivo by peach polyphenolics in a dose range of 0.8–1.6 mg/day, and these effects were mediated by inhibition of metalloproteinase gene expression. Modulation of metalloproteinase-2, metalloproteinase-3, and metalloproteinase-13 gene expression may be some of the molecular targets for anti-metastatic activity of peach polyphenolics. Conversion to equivalent human intake for future clinical studies using the body surface area normalization method gave a dose of approximately 370.6 mg/day for a human adult.

Regarding the kernel-derived compound amygdalin and cancer: amygdalin is a medically interesting but controversial compound, as it has anticancer activity on one hand and can be toxic via enzymatic degradation and production of hydrogen cyanide on the other hand. Despite numerous contributions on cancer cell lines, the clinical evidence for the anticancer activity of amygdalin is not fully confirmed. Amygdalin has been confirmed to be cytotoxic against several cancer lines such as A549, HT-29, MCF-7, and HepG2 in vitro.

Evidence characterization: All anti-cancer evidence for peach polyphenolics is preclinical (in vitro cell lines and xenograft mouse models). No human clinical trials have demonstrated anti-cancer effects of peach or peach polyphenolics. Amygdalin's claimed anti-cancer effects are unconfirmed in controlled clinical trials and carry significant toxicity risk (see Safety section).

5.5 Anti-Inflammatory Activity

Studies have indicated that peach leaves, which are part of the Rosaceae family, have properties that can inhibit tumor growth, reduce inflammation, alleviate allergies, and act as antioxidants. In 2011, Bhattacharjee et al. assessed P. persica leaf aqueous extracts' anti-inflammatory properties, particularly in carrageenan-induced edema, and revealed that P. persica exhibits protective effects against inflammatory disorders in laboratory animals.

Evidence characterization: Anti-inflammatory evidence is animal-model- and in vitro-level only. Human clinical confirmation is absent from the reviewed literature.

5.6 Hepatoprotective Activity

A study conducted in 2015 assessed the hepatoprotective potential of the ethanolic extract of the leaves of P. persica L. using carbon tetrachloride (CCl₄)-treated rats. The results indicated that the ethanolic leaf extract possesses hepatoprotective activity, potentially attributed to the presence of flavonoids.

Evidence characterization: Hepatoprotective evidence is limited to a single animal study. No human data available.

5.7 Skin Health

The essential oil from peach flowers has been shown to protect the skin from UV radiation damage, moisturizing it and preserving elasticity in experimental models. Topical applications of peach-derived extracts have been explored in cosmetic formulations. Extracts are applied topically for soothing skin inflammation in traditional and contemporary practice.

Evidence characterization: Skin-related evidence is primarily preclinical and traditional. Controlled human trials on topical peach preparations were not identified in the reviewed literature.

6. Body Systems and Health Areas Associated with Peach

• Gastrointestinal system: Leaves and flowers are used as mild laxatives and for soothing gastrointestinal irritation in traditional medicine. Dietary fiber in the fruit pulp contributes to regularity.
• Cardiovascular system: Bioactive compounds in peach have been linked to cardioprotective properties in preclinical research, particularly through polyphenol-mediated antioxidant and vasorelaxant mechanisms.
• Metabolic / endocrine system: Evidence has arisen about the preventive effects of peach phenolics on multiple chronic and age-related diseases such as diabetes, obesity, hypertension, and inflammation, though primarily from in vitro and epidemiological data.
• Immune / inflammatory system: Phenolic compounds are reported to be important in the human diet because they can exert a protective effect against oxidative stress, cardiovascular disease, certain cancers, and diseases linked to aging. Polyphenols showcase antioxidant properties that can combat oxidative stress, reduce inflammation, and scavenge and reduce free radicals.
• Oncology (preclinical): Peach polyphenolics show in vitro and animal-model anti-proliferative activity against specific breast cancer cell lines, mediated in part by inhibition of metalloproteinases.
• Gynecological / circulatory system (TCM): Persicae Semen is clinically used in Traditional Chinese Medicine in the treatment of gynecological, cardiovascular, cerebrovascular, orthopedic, and digestive system diseases.
• Respiratory system: Traditionally, peach is used to ease coughs and reduce phlegm.
• Skin: Topical preparations and flower essential oils are associated with UV protection and anti-inflammatory skin effects in experimental settings.

7. Dosage Forms and Dosages Reported in Studies

Dosage data for peach as a therapeutic agent are almost entirely derived from preclinical research. Standardized, clinically validated dosing regimens for humans are not established. The following represents dosage information as stated in specific sources:

• Animal (in vivo) — peach polyphenolics / breast cancer model: Tumor growth and lung metastasis were inhibited in vivo by peach polyphenolics in a dose range of 0.8–1.6 mg/day in the xenograft mouse model. Conversion to equivalent human intake using the body surface area normalization method gave a dose of approximately 370.6 mg/day for a human adult.
• Animal (in vivo) — amygdalin toxicology study: A total of 60 adult rabbits were used; experimental groups received a daily intramuscular injection of amygdalin at doses of 0.6 and 3.0 mg/kg body weight.
• In vitro antioxidant (Tabacchiera peach pulp extract): IC₅₀ values of 2.2 µg/mL (β-carotene bleaching test) and 2.9 µg/mL (Fe-chelating assay) were recorded, but these are laboratory concentrations, not human intake equivalents.

The potential effects of peach seeds and kernels have been reported on the basis of in vitro and in vivo studies, and clinical trials are still required to prove the effectiveness of peach seeds.

8. Safety Considerations and Interactions

8.1 Amygdalin / Cyanogenic Glycoside Toxicity (Kernels/Seeds)

The most well-documented safety hazard associated with peach relates to its kernel (seed), which contains the cyanogenic glycoside amygdalin. Amygdalin is a natural cyanogenic glycoside occurring in the seeds of peaches. It is a medically interesting but controversial compound as it has potential anticancer activity on one hand and can be toxic via enzymatic degradation and production of hydrogen cyanide on the other hand.

The presence of amygdalin in seed kernels is not harmful unless the seed is crushed (masticated) and moistened, allowing release of emulsin. Amygdalin may result in cyanide toxicity in humans. Cyanide is of high acute toxicity in humans, with a lethal dose reported to be 0.5–3.5 mg/kg body weight.

Regarding the laetrile/amygdalin controversy: since the early 1950s, both amygdalin and a chemical derivative named laetrile have been promoted as alternative cancer treatments, often under the misnomer "vitamin B17" (neither amygdalin nor laetrile is a vitamin). Scientific study has found them to not only be clinically ineffective in treating cancer but also dangerous due to considerable poisoning risks.

8.2 Allergic Reactions and Oral Allergy Syndrome

Allergy to peaches (Prunus persica) and nectarines is one of the most common food allergies. In Mediterranean countries, Prunus persica is the most common trigger of plant food allergies.

Two distinct patterns of peach allergy have been characterized: researchers detect two fundamentally different types of allergic reactions to Prunus persica. Sensitization to allergen Pru p 3 produces severe systemic reactions, while sensitization to Pru p 1 or Pru p 4 produces a local response manifesting as oral allergy syndrome (OAS), associated with sensitization to pollen allergens.

The major allergen is the lipid transfer protein Pru p 3: peach allergy sufferers are more than 80% sensitized by the lipid transfer protein Pru p 3. The sensitization is primarily gastrointestinal, probably through consumption of ripe peaches. Pru p 3 is a heat- and acid-stable lipid transfer protein detectable in the skin area at a concentration approximately seven times higher than in the fruit flesh. Therefore, allergy sufferers can often eat peeled fruits without allergic reactions.

OAS to peach has been studied specifically in groups of patients with or without birch pollinosis, as the immune system confuses peach proteins with pollen allergens. Recognized clinical presentations include acute urticaria or angioedema, contact urticaria, laryngeal swelling, immediate vomiting, rhinitis, cough, wheezing, bronchospasm, hypotension or loss of consciousness, oral allergy syndrome (itching and tingling of the lips, oral mucosa, and/or tongue), or food-dependent exercise-induced anaphylaxis.

8.3 Fruit Safety and Processing Considerations

Peach fruit pulp consumed in normal dietary amounts is generally regarded as safe. Fresh peach pulps and peel confer higher protection against cytotoxicity and oxidative stress compared to preserved products. Processing into juices and nectars does not reliably reduce allergenicity: SDS-PAGE and immunoblotting analysis of extracts from four commercial peach nectars showed that the Pru p 1 allergen was not removed, and neither was its allergenic activity decreased by technological treatments carried out for nectar production.

8.4 EFSA Assessment of Kernel Safety (Apricot/Peach Kernels)

While EFSA's formal quantitative assessment addressed primarily apricot kernels, the relevant cyanide risk parameters apply to the amygdalin content of peach kernels as well. An acute reference dose (ARfD) of 20 µg/kg body weight was derived from an exposure associated with a non-toxic blood cyanide level, applying an uncertainty factor of 1.5 for toxicokinetic and 3.16 for toxicodynamic inter-individual differences.

References

• Rafaela Georgé et al. "Prunus persica var. platycarpa (Tabacchiera Peach): Bioactive Compounds and Antioxidant Activity." PubMed, 2015.
• Glatt A. et al. "Determination of Biochemical Composition in Peach (Prunus persica L. Batsch) Accessions Characterized by Different Flesh Color and Textural Typologies." PMC, 2020.
• Bento C. et al. "Peach (Prunus persica (L.) Batsch) seeds and kernels as potential plant-based functional food ingredients: A review of bioactive compounds and health-promoting activities." ScienceDirect, 2023.
• Nangare D.D. et al. "Variation in Minerals, Phenolics and Antioxidant Activity of Peel and Pulp of Different Varieties of Peach (Prunus persica L.) Fruit from Pakistan." PMC, 2018.
• Nowicka P. et al. "Inhibitory Potential against Digestive Enzymes Linked to Obesity and Type 2 Diabetes and Content of Bioactive Compounds in 20 Cultivars of the Peach Fruit Grown in Poland." PMC, 2018.
• He X. et al. "Phenolic Composition and Antioxidant Properties of Different Peach [Prunus persica (L.) Batsch] Cultivars in China." PMC, 2015.
• Vizzotto M. et al. "Effects of different products of peach (Prunus persica L. Batsch) on oxidative stress and inflammatory parameters in vitro and ex vivo." PMC, 2014.
• "Endothelium-Dependent Vasorelaxant Effect of Prunus persica Branch on Isolated Rat Thoracic Aorta." PMC, 2019.
• Jaszczak-Wilke A. et al. "Amygdalin: Toxicity, Anticancer Activity and Analytical Procedures for Its Determination in Plant Seeds." PMC, 2021.
• EFSA. "Acute health risks related to the presence of cyanogenic glycosides in raw apricot kernels and products derived from raw apricot kernels." EFSA Journal, 2016.
• "The anti-proliferative effect of apricot and peach kernel extracts on human colon cancer cells in vitro." PMC, 2019.
• Noratto G. et al. "Polyphenolics from peach (Prunus persica var. Rich Lady) inhibit tumor growth and metastasis of MDA-MB-435 breast cancer cells in vivo." PubMed, 2014.
• Noratto G. et al. "Identifying peach and plum polyphenols with chemopreventive potential against estrogen-independent breast cancer cells." PubMed, 2009.
• Vizzotto M. et al. "Polyphenols of selected peach and plum genotypes reduce cell viability and inhibit proliferation of breast cancer cells while not affecting normal cells." PubMed, 2014.
• Zheng Y. et al. "Archaeological Evidence for Peach (Prunus persica) Cultivation and Domestication in China." PMC, 2014.
• "Genome re-sequencing reveals the evolutionary history of peach fruit edibility." PMC, 2018.
• "Comparative Study of Early- and Mid-Ripening Peach (Prunus persica L.) Varieties: Biological Activity, Macro-, and Micro-Nutrient Profile." PMC, 2021.
• "Fruitomics: The Importance of Combining Sensory and Chemical Analyses in Assessing Cold Storage Responses of Six Peach (Prunus persica L. Batsch) Cultivars." PMC, 2022.
• "Phenotypes and Endotypes of Peach Allergy: What Is New?" PMC, 2022.
• "Peach Leaf Extract (Prunus persica L.) Mitigates Metabolic Syndrome and Oxidative Stress in High-Fructose Diet Rats." PMC, 2025.
• Bento C. et al. "Peach (Prunus Persica): Phytochemicals and Health Benefits." Food Reviews International, 2020.
• Pastorello E.A. et al. "The major allergen of peach (Prunus persica) is a lipid transfer protein." PubMed, 1999.
• Chiva-Blanch G., Badimon L. "Effects of Polyphenol Intake on Metabolic Syndrome: Current Evidences from Human Trials." PMC, 2017.
• "Origins and Genetic Characteristics of Egyptian Peach." PMC, 2024.